PFIZER INC.
- Country
- πΊπΈUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery
- Conditions
- Postoperative Pain
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 277
- Registration Number
- NCT00507026
- Locations
- πΊπΈ
American Institute of Healthcare and Fitness, Raleigh, North Carolina, United States
πΊπΈUniversity Orthopedics Center, State College, Pennsylvania, United States
πΊπΈArizona Research Center, Phoenix, Arizona, United States
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2007-07-18
- Last Posted Date
- 2017-02-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 684
- Registration Number
- NCT00503139
- Locations
- π―π΅
Hokkaido University Hospital, Sapporo, Japan
TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)
- Conditions
- Encephalitis, Tick-Borne
- First Posted Date
- 2007-07-18
- Last Posted Date
- 2015-05-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 314
- Registration Number
- NCT00503529
- Locations
- π΅π±
Hospital in Debica - Zespol Opieki Zdrowotnej w Debicy, Debica, Poland
π΅π±Szpital Jana Pawla II (The John Paul II Hospital) Oddzial Neuroinfekcji, Krakow, Poland
Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus
- First Posted Date
- 2007-07-17
- Last Posted Date
- 2014-08-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 229
- Registration Number
- NCT00502242
- Locations
- πΏπ¦
Pfizer Investigational Site, Cape Town, Western Cape, South Africa
Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects
- Conditions
- Pneumococcal Infections
- Interventions
- Biological: 13-valent Pneumococcal Conjugate Vaccine (13vPnC)
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2011-09-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1053
- Registration Number
- NCT00500266
Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease
- Conditions
- Alzheimer Disease
- Interventions
- Biological: ACC-001 + QS-21Biological: QS-21Biological: ACC-001
- First Posted Date
- 2007-07-10
- Last Posted Date
- 2016-01-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 160
- Registration Number
- NCT00498602
- Locations
- πΊπΈ
Barnes-Jewish Hospital, St. Louis, Missouri, United States
πΊπΈBarrnes-Jewish Hospital at Washington University, St. Louis, Missouri, United States
πΊπΈCUMC Research Pharmacy, New York, New York, United States
Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis
- Conditions
- Candidiasis
- Interventions
- First Posted Date
- 2007-07-04
- Last Posted Date
- 2011-10-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 282
- Registration Number
- NCT00496197
- Locations
- π°π·
Pfizer Investigational Site, Seoul, Korea, Republic of
A Phase 2 Study Of PF-00232798 In HIV Positive Patients
- First Posted Date
- 2007-07-03
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 43
- Registration Number
- NCT00495677
- Locations
- π©πͺ
Pfizer Investigational Site, Koeln, Germany
Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma
- First Posted Date
- 2007-06-29
- Last Posted Date
- 2013-03-21
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 82
- Registration Number
- NCT00494091
- Locations
- π°π·
Pfizer Investigational Site, Seoul, Korea, Republic of
Study Evaluating Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine With Influenza Vaccine in Adults
- Conditions
- Pneumococcal Infections
- Interventions
- Biological: 13-valent pneumococcal conjugate vaccineBiological: 13vPnC + TIV
- First Posted Date
- 2007-06-27
- Last Posted Date
- 2012-02-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1185
- Registration Number
- NCT00492557